Jagsonpal-Pharma Stock/Share Prices, Buy and Sell Jagsonpal-Pharma NSE Stocks

Market Snapshot

BSE Sensex: 38845.82 -0.34%
BSE 500: 15202.64 -0.06%
BSE 200: 4891.61 -0.03%
BSE 100: 11647.17 -0.03%
BSE Mid-Cap: 15047.8 0.26%
BSE Small-Cap: 15299.98 -0.32%
BANKEX: 25035.95 -1.13%
BSE IT Sector: 19852.29 -0.19%
Nifty 50: 11504.95 -0.10%
Nifty 500: 9559.5 -0.08%
Nifty 200: 5981.2 -0.05%
Nifty 100: 11640.2 -0.05%
Nifty Midcap 100: 17399.45 -0.07%
Nifty Small 100: 5991.5 -0.44%
Nifty IT: 19827.05 0.05%
Nifty PSU Bank: 1386.6 -1.62%

News:

Khandwala Securities Ltd leads...
Shilpa Medicare gains after bo...
Volumes jump at Essel Propack ...
Laurus Labs hits record high; ...
Financials stocks slide...

Jagsonpal Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

18 Sep 2020 | 04:14 PM

41.75

0.35 (0.85%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

66.67%

Return (1Y)

Beaten Nifty 50 by 60.54%
More Volatile

3.94%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.97%
Consistent Performer

7/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

News & Announcements

Jagsonpal Pharmaceuticals AGM scheduled
9 days ago

Jagsonpal Pharmaceuticals AGM scheduled

10 - Sep - 2020 12:00 AM | 9 days ago

Jagsonpal Pharmaceuticals announced that the 41th Annual General Meeting (AGM) of the company will be held on 30 September 2020.
Powered by Capital Market - Live News
Board of Jagsonpal Pharmaceuticals recommends final dividend
51 days ago

Board of Jagsonpal Pharmaceuticals recommends final dividend

30 - Jul - 2020 12:00 AM | 51 days ago

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 29 July 2020, inter alia, have recommended the final dividend Rs.of 0.50 per equity share (i.e.10%), subject to the approval of the shareholders.
Powered by Capital Market - Live News
Jagsonpal Pharmaceuticals standalone net profit rises 26.00% in the June 2020 quarter
52 days ago

Jagsonpal Pharmaceuticals standalone net profit rises 26.00% in the June 2020 quarter

29 - Jul - 2020 12:00 AM | 52 days ago

Net profit of Jagsonpal Pharmaceuticals rose 26.00% to Rs 2.52 crore in the quarter ended June 2020 as against Rs 2.00 crore during the previous quarter ended June 2019. Sales declined 30.02% to Rs 31.65 crore in the quarter ended June 2020 as against Rs 45.23 crore during the previous quarter ended June 2019.
Particulars Quarter Ended
Jun. 2020 Jun. 2019 % Var.
Sales 31.65 45.23 -30
OPM % 8.37 4.95 -
PBDT 3.30 2.79 18
PBT 3.03 2.50 21
NP 2.52 2.00 26
Powered by Capital Market - Live News

Jagsonpal Pharmaceuticals standalone net profit declines 47.81% in the March 2020 quarter

52 days ago

Price vs Volume

Stock Trivia

Jagsonpal Pharmaceuticals Ltd has opened at 36.75 i.e 3.38% above then yesterday's closing price of 35.55

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended			Year Ended
	Mar. 2020	Mar. 2019	% Var.	Mar. 2020	Mar. 2019	% Var.
Sales	29.52	38.40	-23	158.57	166.83	-5
OPM %	4.13	8.85	-	5.37	5.60	-
PBDT	1.83	4.01	-54	10.54	10.03	5
PBT	1.51	3.73	-60	9.41	9.01	4
NP	1.55	2.97	-48	7.87	7.22	9

Particulars	Quarter Ended
	Jun. 2020	Jun. 2019	% Var.
Sales	31.65	45.23	-30
OPM %	8.37	4.95	-
PBDT	3.30	2.79	18
PBT	3.03	2.50	21
NP	2.52	2.00	26

General Notifications

My Notifications

Research Notifications

Jagsonpal Pharmaceuticals Ltd NSE / BSE Pharmaceuticals, Small Cap

41.75 0.35 (0.85%)

News & Announcements

Price vs Volume

Stock Trivia

Jagsonpal Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Small Cap

41.75

0.35 (0.85%)